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Several recent reports have documented the
reduction in hospital stay and intensive care unit
(ICU) stay associated with the endovascular repair
of abdominal aortic aneurysms (AAAs).1-3 These
studies well document the safety and efficacy of
endovascular aneurysm repair using currently avail-
able, commercially produced grafts. The potential
for significant reductions in hospital inpatient stay
and ICU care, along with improvement in patient
recovery time, offers the opportunity to realize sig-
nificant reduction in the cost of AAA repair.
A number of studies have documented the sig-
nificant economic burden associated with the tradi-
tional open repair of AAAs.4,5 More recently,
Holzenbein et al6 suggested that potential cost sav-
ings may be realized through the use of endovascu-
lar techniques to repair AAA. The present study was
undertaken to evaluate the impact of endovascular
devices on health care costs at the Cleveland Clinic
Foundation.
METHODS
Patients undergoing open repair of an AAA by
means of a traditional open surgical method (OS),
between January 1 and October 1, 1998, were iden-
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tified from a prospective surgical registry comprising
all vascular surgical procedures performed at the
Cleveland Clinic Foundation. The Cleveland Clinic
is a large multispecialty group with a vascular surgi-
cal department that consists of six surgeons per-
forming procedures at the main facility. All patients
in this study were treated by these physicians.
Patients undergoing emergent repair for ruptured
aneurysms were excluded from this cost evaluation.
Patients underwent operative repair through a
midline or retroperitoneal approach, depending on
surgeon preference. In all instances aortic cross-
clamping was performed in an infrarenal position. A
coated polyester prosthesis (Hemashield; Boston
Scientific Corporation, Boston, Mass) was used for
repair of these infrarenal aneurysms. Devices were
placed in a tube graft or bifurcated configuration,
depending on patient anatomy and extent of
aneurysmal and occlusive disease.
Patients undergoing endovascular repair were
identified from a separate registry of patients under-
going endovascular surgical repair (ES) of AAA.
Endovascular repair was performed by means of
bilateral groin incisions for exposure of the femoral
arteries. A modular device composed of a polyester
prosthesis covered with a nitinol exoskeleton
(AneuRx; Medtronic, Sunnyvale, Calif) was placed
in an infrarenal position through transverse femoral
arteriotomies. Additional aortic and iliac extensions
of this device were added as necessary to obtain
angiographic evidence of an adequate seal at the
proximal and distal attachment sites.
Demographic data were compiled from these
two registries. Additionally, evaluation of operative
time, ICU time, hospital length of stay, and morbid-
ity and mortality rates was compiled from registry
and hospital records. Where appropriate, these data
were compared with χ2 statistics or the Student t test
to assess differences between the two groups.
Pulmonary complications were defined as the
postoperative need for intubation or reintubation.
Renal complications were deemed present when
there was an elevation of the serum creatinine level
greater than 2 mg/dL during the postoperative
period.
Data regarding direct costs for care of patients
were compiled using the database of Transition
Systems, Inc (Boston, Mass). This system accrues
cost data on all patients admitted and maintains
those costs for each hospital admission. Costs calcu-
lated included only inhospital costs. This study did
not include out-of-hospital costs related to the dif-
ferent types of aneurysm repair. Additionally, this
study did not evaluate physician charges. Costs are
calculated in nine different cost centers to assess
costs related to different working areas in the hospi-
tal. These cost centers are anesthesia, the emergency
department, laboratory medicine, ICU costs, oper-
ating room material used (OR tech), regular nursing
floor materials, catheters and other miscellaneous
materials (cath/other), pharmacy, and radiology.
Costs were calculated overall and in the different
cost centers on a per case basis and then averaged to
obtain an average cost per case associated with each
of the two types of repairs. Comparisons were made
between the costs for the two different types of
repair with the use of the Student t test.
RESULTS
There were 139 patients who underwent non-
emergent repair of infrarenal AAA during the 10-
month study period. Of these, 94 patients under-
went an open repair and comprised the OS group,
whereas 45 patients underwent endovascular repair
and comprised the ES group. Patients in the ES
group were older than those in the OS group (Table
I). Operative times and length of stay in the hospital
and ICU were all markedly shorter in the ES group
(Table II). Mortality and morbidity rates for the two
groups were similar (Table III). There were no doc-
umented myocardial infarctions in either group.
Pulmonary and renal complications occurred with a
frequency that was not statistically different. The
endoleak rate for patients in the ES group as evalu-
Table I. Demographic data
Endovascular repair Open surgical repair
(ES) n = 45 (OS) n = 94 P value
Age (y) 75.5 71.1 .001
Sex
Male 39 (86.6%) 78 (83.0%) .58
Female 6 (13.4%) 16 (17.0%)
Coronary artery disease 30 (66.7%) 52 (53.5%) .20
Chronic pulmonary disease 19 (42.2%) 29 (31.3%) .18
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ated by duplex ultrasound scan was 17.8% at 1
month from the time of repair.
Cost differences between the two groups are rep-
resented in the Figure. Current hospital policy pre-
cludes the inclusion of absolute cost dollars but does
allow for the presentation of cost differences; there-
fore, only differences in cost are evaluated.
Differences are shown between the two groups in
each of the separate cost centers and in total direct,
indirect, and overall costs. Costs for the ES group
outpaced those for the OS group in only two cost
centers of the ten into which items were broken
down (cath/other, OR tech.) The largest difference
between the groups was noted in the OR technical
costs. These costs reflected the cost of implantable
items as well as those materials needed for placement
of the device. The cost difference in this cost center
was primarily related to the difference in the costs of
the prostheses, a difference that drove the total
direct cost of endovascular surgical repair to be
greater than that of open surgical repair.
DISCUSSION
A number of distinct economic parameters are in
widespread use to analyze the cost of care of a hos-
pitalized patient. Direct cost refers to those
resources used by an institution that are consumed
as a result of a patient admission. As such, these costs
are variable and depend on the volume and com-
plexity of admissions. By contrast, indirect cost
refers to the use of resources that are independent of
patient volume. Indirect costs are fixed and comprise
expenditures required for such items as electricity
and plant maintenance. In health care institutions,
these costs are not altered by methods of care and
are relatively stable over time. These costs also
include fixed personnel costs borne by hospitals
independent of the care provided by physicians.
When the attempt is made to evaluate the finan-
cial impact of a particular procedure, it is most appro-
priate to calculate the effect a practice change will
have on the direct cost of the new type of care, com-
pared with the direct cost of standard care. Analyzing
data in this way allows a comparison of capital expen-
diture that a health care institution makes for specific
patients and the care they require. There is no need
for complex formulas to attempt to relate the cost of
care. One can simply sum the costs associated with
any given patient encounter to arrive at a relatively
accurate assessment of the true financial impact.
Endovascular aneurysm repair offers reductions
in hospitalization and recovery times. However,
patients undergoing this procedure often require
significant additional imaging beforehand and more
significant imaging afterward. The current study did
not evaluate these additional costs related to the
endovascular technique. Although these costs repre-
sent an addition to the overall costs of this type of
repair, this study shows that endovascular repair
incurs greater health care institution costs during
hospitalization for repair. Additional costs related to
preoperative and postoperative evaluation will fur-
ther increase the cost difference between these two
types of repair.
Table II. Operative times and length of stay for patients undergoing endovascular and open repair of AAA
Endovascular repair Open surgical repair 
(ES) n = 45 (OS) n = 99 P value
OR time (min) 166 ± 53 285 ± 86 < .001
ICU length of stay (d) 0.06 ± 0.25 2.97 ± 3.22 < .001
Length of stay (d) 3.2 ± 1.4 9.7 ± 4.8 < .001
AAA, Abdominal aortic aneurysm; ICU, intensive care unit; OR, operating room.
Table III. Outcomes for patients undergoing endovascular and open repair of AAA
Endovascular repair (ES) n = 45 Open surgical repair (OS) n = 94
Mortality 0 1 (1.1%)
Pulmonary complications 1 (2.2%) 4 (4.3%)
Renal complications (ARF) 2 (4.5%) 1 (1.1%)
Graft limb thrombosis 2 (4.5%) 0
Wound dehiscence 1 (2.2%) 1 (1.1%)
ARF, Acute renal failure. 
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This study represents a comparison of concur-
rent groups of patients who underwent two differ-
ent methods of AAA repair. The patients in the ES
group were slightly older than their counterparts in
the OS group. With advanced age and comorbidities
in the ES group, one might expect higher pharmacy,
laboratory, and floor nursing care costs. However,
patients in the ES group had lower costs in all these
areas. In spite of reduced costs in these areas, the
overall direct cost of patient care was significantly
higher than in the OS group.
Evaluation of the cost difference between the
two groups reveals a significantly lower direct cost
for those patients in the OS group ($7205). These
costs do not account for reduction in hospitalization
time or potential savings in indirect costs that may
be generated by the ES group. Indirect cost differ-
ence between the two groups should take some
account of this. Indirect cost remains a difficult
quantity to calculate without complex formulas
relating cost of care to fixed institutional costs.
Additionally, patients may use the items contained in
these costs to varying degrees. When one calculates
the difference in total cost (direct and indirect)
between the two groups, the difference is approxi-
mately $3000. By knowing the cost of implantable
items ($8926) for the ES group, one can see that
bringing the total costs of the groups to parity will
require the cost of the graft to be limited to $6000.
Although this figure would better equate the costs
of the two procedures, this preliminary finding clear-
ly needs to be studied further, and additional costs
(eg, outpatient costs) for the two types of repair
need to be assessed as part of a more definitive analy-
sis as well.
Several authors have evaluated hospital costs as
related to AAA repair.4,7 These authors have calcu-
lated overall costs with a formula that derived cost
associated with indirect cost of care for these
patients. Although investigators effectively evaluate
costs associated with AAA repair in these studies,
they do not evaluate direct costs of care. Moreover,
the model does not allow an evaluation of how
changing trends in patient care can modify the cost
of treating a medical problem.
More recently, Holzenbein et al6 reported on a
study of cost comparison between endovascular and
open surgical repair of AAAs. With 22 patients in
each group, these authors sought to determine if it
was economically sensible to pursue endovascular
repair of AAAs. In their study, the authors found
that the cost of endovascular repair was substantially
less than that of standard surgical repair. In the cal-
culation of costs for the hospital stay of these
patients, however, a calculated cost of hospitaliza-
tion was computed for time spent in the ICU and on
the hospital ward. These calculations were based on
relatively arbitrary assumptions of the standard costs
of patient care resource use. This methodology
ignores those costs that are related to the particular
intervention under question. For instance, the cost
of the endovascular prosthesis is not included. When
Difference in cost between endovascular and open surgical repair of AAA (see text for descrip-
tion of cost centers). Positive numbers indicate greater costs in the endovascular group.
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such costs are included in the analysis, as it was done
in the present study, the economic impact of
endovascular aortic repair is quite different. As long
as the cost of the endovascular prostheses remains
high, the financial feasibility of endovascular tech-
niques is questionable. The resulting paradox is
unfortunate, wherein a procedure of potentially
great benefit to patients may be denied on the basis
of exorbitant cost.
REFERENCES
1. Zarins CK, White RA, Schwarten D, Kinney E, Diethrich EB,
Hodgson KJ, et al. AneuRx stent graft versus open surgical
repair of abdominal aortic aneurysms: multicenter prospec-
tive clinical trial. J Vasc Surg 1999;29:292-305.
2. May J, White GH, Waugh R, Stephen MS, Chaufour X, Yu
W. Adverse events after endoluminal repair of abdominal aor-
tic aneurysms: a comparison during two successive periods of
time. J Vasc Surg 1999;29:32-9.
3. May J, White GH, Yu W, Waugh R, Stephen M, Harris JP.
Concurrent comparison of endoluminal repair vs no treat-
ment for small abdominal aortic aneurysms. Eur J Vasc
Endovasc Surg 1997;13:472-6.
4. Benzaquen BS, Eisenberg MJCR, Nguyen T, Brown KJ,
Topol EJ. Correlates of in-hospital cost among patients
undergoing abdominal aortic aneurysm repair. Am Heart J
1998;136:696-702.
5. Swiwert AJ, Elmore JR, Youkey JR, Franklin DP. Ruptured
abdominal aortic aneurysm repair: the financial analysis. Am
J Surg 1995;170:91-6.
6. Holzenbein J, Kretschmer G, Glanzl R, Schron A, Thurnher
S, Winkelbauer R, et al. Endovascular AAA treatment: expen-
sive prestige or economic alternative? Eur J Vasc Endovasc
Surg 1997;14:265-72.
7. Breckwoldt WL, Mackey WC, O’Donnell TFJ. The econom-
ic implications of high-risk abdominal aortic aneurysms. J
Vasc Surg 1991;13:798-804.
Submitted Apr 29, 1999; accepted Nov 23, 1999.
TABLE OF CONTENTS BY E-MAIL
To receive the tables of contents by e-mail, sign up through our website at:
http://www.mosby.com/jvs
Choose E-mail Notification.
Simply type your e-mail address in the box and click the Subscribe button.
Alternatively, you may send an e-mail message to majordomo@mosby.com. 
Leave the subject line blank and type the following as the body of your message:
subscribe jvs_toc
You will receive an e-mail to confirm that you have been added to the mailing list. 
Note that TOC e-mails will be sent out when a new issue is posted to the website.
